Exact Sciences
Developer and manufacturer of cologuard, a non-invasive screening test for the early detection of colorectal cancer. Learn more
Launch date
Employees
Market cap
€11.3b
Enterprise valuation
€13.0b (Public information from Sep 2024)
Share price
$70.83 EXAS
Madison Wisconsin (HQ)
No columns specified